Results

Total Results: 129 records

Showing results for "venous".

21. Evidence Summary: Elevated Blood Lead Levels in Children and Pregnant Women: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/elevated-blood-lead-levels-in-childhood-and-pregnancy-screening
    April 16, 2019 - CI, 31.4% to 65.6%) and specificity of 58% (95% CI, 39.9% to 74.0%) for identifying children with a venous … lead testing demonstrated sensitivity of 87% to 91% and specificity greater than 90%, compared with venous … Testing approaches included studies of screening questionnaires and venous or capillary blood lead testing … for KQ1 were screening vs no screening; for KQ2a, a questionnaire against a reference standard (ie, venous … Screening for pediatric lead poisoning: comparability of simultaneously drawn capillary and venous blood

22. Draft Recommendation: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/menopausal-hormone-therapy-postmenopausal-persons-primary-prevention-chronic-conditions
    April 19, 2022 - In the WHI (n=16,608), persons randomized to estrogen plus progestin had an increased risk of venous … Estrogen plus progestin and risk of venous thrombosis. JAMA . 2004;292(13):1573-1580. 26. … progestin is associated with moderate harms, including increased risk of invasive breast cancer, stroke, venous … evidence that use of estrogen alone is associated with moderate harms, including increased risk of stroke, venous

23. Archived: Elevated Lead Levels in Childhood and Pregnancy: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/elevated-lead-levels-childhood-pregnancy-screening-1996
    January 01, 1996 - contribute to higher false-positive rates for initial capillary samples when compared to results from venous … randomized controlled trial assessing the effect of chelation therapy on IQ in young children with venous … Third, measurement of venous blood lead concentration is a convenient, reliable, precise and reasonably … If capillary blood is used, elevated lead levels should be confirmed by measurement of venous blood lead … Screening for pediatric lead poisoning: comparability of simultaneously drawn capillary and venous blood

24. Draft Research Plan: Hypertensive Disorders of Pregnancy: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/hypertensive-disorders-pregnancy-screening
    May 20, 2021 - infarction Renal or hepatic injury/failure Pulmonary edema, adult respiratory distress syndrome Venous

25. USPSTF Clinician Summary of USPSTF Recommendation: Screening for Latent Tuberculosis Infection in Adults (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/nV4GCeHGsZrfKUWxo9_zZb
    April 01, 2023 - • The IGRA requires a single venous blood sample that measures the CD4 T-cell response to specific

26. Final Research Plan: Hypertensive Disorders of Pregnancy: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hypertensive-disorders-pregnancy-screening
    September 02, 2021 - infarction Renal or hepatic injury/failure Pulmonary edema, adult respiratory distress syndrome Venous

27. Evidence Summary: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary28/menopausal-hormone-therapy-preventive-medication
    November 01, 2022 - cases; 377 more [95% CI, 234-540]), stroke over 7.2 years (318 vs 239 cases; 79 more [95% CI, 15-159]), venous … vs 463 cases; 260 more [95% CI, 169-364]), stroke (187 vs 135 cases; 52 more [95% CI, 12-104]), and venous … Venous thrombosis and conjugated equine estrogen in women without a uterus. … Estrogen plus progestin and risk of venous thrombosis. … Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the

28. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/sTjqbTas6gW5pzaATpeBDn
    January 01, 2013 - evidence that estro- gen and progestin therapy is associated with a small in- creased risk for deep venous … serious adverse events, such as stroke, invasive breast cancer, dementia, gallbladder disease, deep venous … , but it is also associated with important harms, such as an increased likelihood of stroke, deep venous … Benefits Total fractures 46 (29 to 63) – Hip fracture 6 (1 to 10) – Harms Stroke – 9 (2 to 15) Deep venous … 3) – Total fractures 56 (37 to 75) – Hip fracture 7 (1 to 12) – Harms Stroke – 11 (2 to 20) Deep venous

29. Archived: Final Research Plan: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication-december-2017
    October 22, 2015 - contraindications for hormone therapy use, such as history of breast cancer, coronary heart disease, previous venous

30. Medicines to Help Prevent Breast Cancer: Let's Talk About It (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide_3.pdf
    September 01, 2019 - difference no difference Fractures Cataracts Endometrial Cancer (cancer of the uterus) Blood Clots (venous

31. Medicines to Help Prevent Breast Cancer: Let's Talk About It (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide.pdf
    September 01, 2019 - difference no difference Fractures Cataracts Endometrial Cancer (cancer of the uterus) Blood Clots (venous

32. Draft Research Plan: Menopausal Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/menopausal-hormone-therapy-postmenopausal-women-primary-prevention-chronic-conditions
    February 18, 2021 - contraindications for HT use, such as history of breast cancer, coronary heart disease, a previous venous

33. Draft Research Plan: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/menopausal-hormone-therapy-postmenopausal-persons-primary-prevention-chronic-conditions
    February 18, 2021 - contraindications for HT use, such as history of breast cancer, coronary heart disease, a previous venous

34. Archived: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-december-2017
    December 12, 2017 - progestin is associated with moderate harms, including increased risk of invasive breast cancer and venous … harms, including increased risk of stroke, dementia, gallbladder disease, urinary incontinence, and venous … which varied in study duration and outcome measures, there was no significant difference in risk of venous … One trial of estrogen alone (EPAT 20 ) reported no venous thromboembolic events in either group during … probable) a 22 (4 to 53) Gallbladder disease 21 (10 to 34) Stroke 9 (2 to 19) Venous

35. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Rn7dRezgMx5syB-erQKoKt
    November 01, 2022 - cases; 377 more [95% CI, 234-540]), stroke over 7.2 years (318 vs 239 cases; 79 more [95% CI, 15-159]), venous … vs 463 cases; 260 more [95% CI, 169-364]), stroke (187 vs 135 cases; 52 more [95% CI, 12-104]), and venous … Venous thrombosis and conjugated equine estrogen in women without a uterus. … Estrogen plus progestin and risk of venous thrombosis. … Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the

36. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/VKGPkVjto7K4yfUHBKEHBA
    January 01, 2025 - progestin is associated with moderate harms, including increased risk of invasive breast cancer and venous … harms, including increased risk of stroke, dementia, gallbladder disease, urinary incontinence, and venous … 0 to 18) Dementia (probable)a 22 (4 to 53) Gallbladder disease 21 (10 to 34) Stroke 9 (2 to 19) Venous … Harms Dementia (probable)a 12 (−4 to 41) Gallbladder disease 30 (16 to 48) Stroke 11 (2 to 23) Venous … One trial of estrogen alone (EPAT20) reported no venous thromboembolic events in either group during

37. Recommendation: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication
    November 01, 2022 - In the WHI (n = 16,608), persons randomized to estrogen plus progestin had an increased risk of venous … Estrogen plus progestin and risk of venous thrombosis. JAMA . 2004;292(13):1573-1580. 27. … progestin is associated with moderate harms, including increased risk of invasive breast cancer, stroke, venous … evidence that use of estrogen alone is associated with moderate harms, including increased risk of stroke, venous

38. Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer
    April 11, 2016 - Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med . 2012;367:1979-87. … CVD = cardiovascular disease; DAMAD = Dipyridamole Aspirin Microangiopathy of Diabetes; DVT = deep venous … Atherosclerosis; AMIS = Aspirin Myocardial Infarction Study; ASPIRE = Aspirin to Prevent Recurrent Venous … for Asymptomatic Atherosclerosis; ABI = ankle–brachial index; ASPIRE = Aspirin to Prevent Recurrent Venous … Thromboembolism; BMD = British Male Doctors; CVD = cardiovascular disease; DVT = deep venous thrombosis

39. Archived: Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med . 2012;367:1979-87. … CVD = cardiovascular disease; DAMAD = Dipyridamole Aspirin Microangiopathy of Diabetes; DVT = deep venous … Atherosclerosis; AMIS = Aspirin Myocardial Infarction Study; ASPIRE = Aspirin to Prevent Recurrent Venous … for Asymptomatic Atherosclerosis; ABI = ankle–brachial index; ASPIRE = Aspirin to Prevent Recurrent Venous … Thromboembolism; BMD = British Male Doctors; CVD = cardiovascular disease; DVT = deep venous thrombosis

40. Draft Recommendation: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/latent-tuberculosis-infection-adults
    November 22, 2022 - protein derivative and interpret the response 48 to 72 hours later. 25 , 27 IGRA requires a single venous … Screening with an IGRA requires obtaining a single venous blood sample, and patients do not need to return … However, clinicians should be aware of processing requirements for blood samples and ensure that venous